GetTopicDetailResponse(id=5bb299e086e, topicName=非選擇性β受體阻滯劑, introduction=非選擇性β受體阻滯劑, content=null, image=null, comments=0, allHits=1080, url=https://h5.medsci.cn/topic?id=99708, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=35813, tagList=[TagDto(tagId=35813, tagName=非選擇性β受體阻滯劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2254256, encodeId=ca2c2254256e4, content=<a href='/topic/show?id=5bb299e086e' target=_blank style='color:#2F92EE;'>#非選擇性β受體阻滯劑#</a> <a href='/topic/show?id=488344261c3' target=_blank style='color:#2F92EE;'>#失代償期肝硬化#</a>, objectTitle=非選擇性β受體阻滯劑對失代償期肝硬化患者的影響：根據(jù)MELD評分進(jìn)行獲益和風(fēng)險分層, objectType=article, longId=865294, objectId=b8e5865294d2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250114/1736847778037_8538692.png, objectUrl=/article/show_article.do?id=b8e5865294d2, replyNumber=0, likeNumber=25, createdTime=2025-03-02, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=b8e5865294d2, moduleTitle=非選擇性β受體阻滯劑對失代償期肝硬化患者的影響：根據(jù)MELD評分進(jìn)行獲益和風(fēng)險分層, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b8e5865294d2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2247368, encodeId=b7b6224e36827, content=<a href='/topic/show?id=cb65813029a' target=_blank style='color:#2F92EE;'>#肝硬化#</a> <a href='/topic/show?id=631610111efb' target=_blank style='color:#2F92EE;'>#食管胃靜脈曲張出血#</a> <a href='/topic/show?id=5bb299e086e' target=_blank style='color:#2F92EE;'>#非選擇性β受體阻滯劑#</a>, objectTitle=UEGJ：肝硬化胃靜脈曲張出血的二級預(yù)防, objectType=article, longId=858748, objectId=8c88858e48a5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240925/1727233846342_8538692.png, objectUrl=/article/show_article.do?id=8c88858e48a5, replyNumber=0, likeNumber=66, createdTime=2025-01-09, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=8c88858e48a5, moduleTitle=UEGJ：肝硬化胃靜脈曲張出血的二級預(yù)防, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8c88858e48a5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2224180, encodeId=26b2222418073, content=<a href='/topic/show?id=cb65813029a' target=_blank style='color:#2F92EE;'>#肝硬化#</a> <a href='/topic/show?id=ea799e1628b' target=_blank style='color:#2F92EE;'>#門靜脈高壓#</a> <a href='/topic/show?id=5bb299e086e' target=_blank style='color:#2F92EE;'>#非選擇性β受體阻滯劑#</a>, objectTitle=APT：非選擇性β受體阻滯劑與肝硬化危重患者死亡率降低相關(guān), objectType=article, longId=841908, objectId=832d841908ae, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=832d841908ae, replyNumber=0, likeNumber=114, createdTime=2024-09-05, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=832d841908ae, moduleTitle=APT：非選擇性β受體阻滯劑與肝硬化危重患者死亡率降低相關(guān), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=832d841908ae)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
